Skip to content
SOCI - Standing Committee

Social Affairs, Science and Technology

Meeting Detail

Friday, June 6, 2014
8:03 AM ET
Location: Room 256-S, Centre Block
Clerk: Jessica Richardson (613) 990-6087
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
  • Amir Attaran, Canadian Research Chair, Population Health and Global Development Policy, University of Ottawa(As an individual)
  • Jack Corman, President(Institutional Review Board Services)
  • Janet Currie, Representative(Psychiatric Medication Awareness Group)
  • Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc.(Canadian Generic Pharmaceutical Association)
  • Perry Eisenschmid, Chief Executive Officer(Canadian Pharmacists Association)
  • Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services(Canadian Institute for Health Information)
  • Matthew Herder, Assistant Professor, Health Law Institute, Faculties of Medicine and Law, Dalhousie University(As an individual)
  • Ronald Heslegrave, Executive Director, William Osler Health System(As an individual)
  • Dr. David Juurlink, Head, Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre(Institute for Clinical Evaluative Sciences)
  • Brian O'Rourke, President and Chief Executive Officer(Canadian Agency for Drugs and Technologies in Health)
  • Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network(Canadian Institutes of Health Research)
  • Jared Rhines, Vice-president, Scientific and Strategic Affairs(Rx&D)
  • Tina Saryeddine, Assistant Vice-President, Research and Policy Analysis(HealthCareCAN (formerly ACAHO-CHA))
  • Maureen Smith, Secretary(Canadian Organization for Rare Disorders)
  • Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy & Management, Faculty of Health, York University(As an individual)
  • Jennifer Zelmer, Executive Vice-President(Canada Health Infoway)
Meeting with interpretation and transcription
Back to top